Wealth Enhancement Advisory Services LLC Has $2.65 Million Position in The Cooper Companies, Inc. $COO

Wealth Enhancement Advisory Services LLC lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 212.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,455 shares of the medical device company’s stock after purchasing an additional 21,383 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Cooper Companies were worth $2,652,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its stake in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. JANA Partners Management LP bought a new stake in shares of Cooper Companies during the third quarter worth $166,917,000. Capital World Investors increased its holdings in shares of Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Cooper Companies by 98.8% during the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after buying an additional 1,683,561 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in shares of Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after acquiring an additional 1,525,693 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent research reports. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a report on Wednesday, March 4th. Wells Fargo & Company upped their target price on Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, December 5th. Piper Sandler reiterated an “overweight” rating and issued a $94.00 target price (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Mizuho set a $100.00 price target on Cooper Companies and gave the company an “outperform” rating in a research note on Friday, December 5th. Finally, Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Stock Down 0.1%

COO stock opened at $71.43 on Thursday. The stock’s 50 day simple moving average is $78.15 and its 200 day simple moving average is $76.23. The company has a market cap of $13.94 billion, a P/E ratio of 35.36, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.